<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03458091</url>
  </required_header>
  <id_info>
    <org_study_id>A-THRIVE</org_study_id>
    <nct_id>NCT03458091</nct_id>
  </id_info>
  <brief_title>Evaluation of Lung Atelectasis During Apneic Oxygenation Using THRIVE in Adults During Laryngeal Surgery.</brief_title>
  <acronym>A-THRIVE</acronym>
  <official_title>Evaluation of Lung Atelectasis During Apneic Oxygenation Using Trans Nasal Humidified Rapid Insufflation Ventilatory Exchange (THRIVE) in Adults During Laryngeal Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Oxygenation with high-flow nasal cannula with 100% oxygen have now been evaluated in a number&#xD;
      of studies and the data are convincing. The THRIVE technique is able to oxygenate patients&#xD;
      safely and vital parameters has been shown to be stable. But it is of great importance to&#xD;
      evaluate this new concept regarding other potential negative physiological aspects such as&#xD;
      lung atelectasis and inflammatory stress response before implementing it into clinical&#xD;
      practice.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 22, 2018</start_date>
  <completion_date type="Actual">October 10, 2020</completion_date>
  <primary_completion_date type="Actual">October 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Electrical impedans tomography</measure>
    <time_frame>baseline, intraoperative, 2 hours after start of intervention</time_frame>
    <description>Changes in lung volumes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in Endtidal and arterial carbon dioxide partial pressure in the end of the procedure</measure>
    <time_frame>max 30 minutes after start of intervention</time_frame>
    <description>Difference in Endtidal and arterial carbon dioxide partial pressure in the end of the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increase in arterial carbon dioxide during the apnea</measure>
    <time_frame>max 30 minutes after start of intervention</time_frame>
    <description>Measurement of arterial blood gases and here arterial carbon dioxide</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Intubation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will be intubated and ventilated</description>
  </arm_group>
  <arm_group>
    <arm_group_label>THRIVE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients will be oxygenated during apnea using THRIVE</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>THRIVE</intervention_name>
    <description>Oxygenation during apnea using transversal humidified oxygen</description>
    <arm_group_label>THRIVE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endotracheal intubation</intervention_name>
    <description>Ventilation during the procedure is governed by an endotracheal tube in the trachea and mechanical ventilation</description>
    <arm_group_label>Intubation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adults, &gt;18 years old.&#xD;
&#xD;
          2. ENT-surgery where apnea is of benefit for the surgeon (eg. intraoral or laryngeal&#xD;
             surgery).&#xD;
&#xD;
          3. Capable of understanding the study information and sign the written consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. ASA&gt;2&#xD;
&#xD;
          2. NYHA &gt;2&#xD;
&#xD;
          3. Pacemaker or ICD.&#xD;
&#xD;
          4. BMI &gt;35&#xD;
&#xD;
          5. Pregnancy&#xD;
&#xD;
          6. Manifest cardiac failure or coronary disease&#xD;
&#xD;
          7. Severe gastrointestinal reflux.&#xD;
&#xD;
          8. Neuromuscular disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Malin Jonsson Fagerlund</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska University Hospital and Karolinska Institutet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>January 21, 2018</study_first_submitted>
  <study_first_submitted_qc>March 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2018</study_first_posted>
  <last_update_submitted>October 13, 2020</last_update_submitted>
  <last_update_submitted_qc>October 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Malin Jonsson Fagerlund</investigator_full_name>
    <investigator_title>Senior Consultant, Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Atelectasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

